| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 11 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zhou Shuliang | 11 |
| #2 | Wang Peng | 8 |
| #3 | Deng Lan | 8 |
| #4 | Pan Wenqiang | 3 |
| #5 | Dai Jingying | 2 |
| #6 | Huang Xiaobing | 2 |
| #7 | Chong Huihui | 1 |
| #8 | Zhu Yuanmei | 1 |
| #9 | He Yuxian | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN111410687A | Long-acting G L P-1 compound | |
| CN111423506A | G L P-1 compound | |
| CN111675752A | Coronavirus membrane fusion inhibitor and pharmaceutical application thereof | |
| CN111333714A | Long-acting GLP-1 compound | |
| CN111285923A | PSD-95 inhibitor | |
| CN111303245A | Anti-syncytial virus membrane fusion inhibitor | |
| CN110642935A | Tirapapotide analogue | |
| CN110642753A | Amino acid derivative | |
| CN110627877A | PSD-95 inhibitor |